Stock Quote

Copyright Nasdaq. Minimum 15 minutes delayed.

Investor Overview

Corporate Profile

Stryker is one of the world’s leading medical technology companies and, together with its customers, is driven to make healthcare better. The company offers innovative products and services in Orthopaedics, Medical and Surgical, and Neurotechnology and Spine that help improve patient and hospital outcomes.


Toggle Summary Stryker declares a $0.47 per share quarterly dividend
Kalamazoo, Michigan - August 1, 2018 - Stryker Corporation (NYSE:SYK) announced that its Board of Directors has declared a quarterly dividend of $0.47 per share payable on October 31, 2018 to shareholders of record at the close of business on September 28, 2018 , representing an increase of
Toggle Summary Stryker reports second quarter 2018 operating results
Reported net sales increased 10.3% to $3.3 billion Organic net sales increased 7.9% Reported operating income margin of 20.2% Adjusted operating income margin (1) expanded 70 bps (50 bps excluding ASC 606 (2) ) to 25.7% Reported EPS increased 15.5% to $1.19 Adjusted EPS (3) increased 15.0% to $1.76
Toggle Summary Stryker announces organizational changes
Kalamazoo, Michigan - July 10, 2018 - Stryker Corporation (NYSE:SYK) announced today that David K. Floyd , Group President, Orthopaedics has notified the Company of his intent to retire on June 30, 2019. Until this date, Mr. Floyd will serve as Group President and Advisor to the CEO and will assist
Toggle Summary Stryker announces definitive agreement to acquire SafeAir AG
Kalamazoo, Michigan - June 25, 2018 - Stryker Corporation (NYSE:SYK) announced today a definitive agreement to acquire SafeAir AG , a Swiss medical device company dedicated to the design, development and manufacture of innovative surgical smoke evacuation solutions.


There are currently no events to display.
Investor Contacts
Katherine A. Owen
Vice President, Strategy & Investor Relations
Stryker Corporation
2825 Airview Boulevard
Kalamazoo, MI 49002